Prospective validation of a model-informed precision dosing tool for vancomycin in intensive care patients

Rob ter Heine, Ron J. Keizer, Krista van Steeg, Elise J. Smolders, Matthijs van Luin, Hieronymus J. Derijks, Cornelis P.C. de Jager, Tim Frenzel, Roger Brüggemann

Onderzoeksoutput: Bijdrage aan tijdschriftArtikelpeer review

25 Citaten (Scopus)


Aims: Vancomycin is an important antibiotic for critically ill patients with Gram-positive bacterial infections. Critically ill patients typically have severely altered pathophysiology, which leads to inefficacy or toxicity. Model-informed precision dosing may aid in optimizing the dose, but prospectively validated tools are not available for this drug in these patients. We aimed to prospectively validate a population pharmacokinetic model for purpose model-informed precision dosing of vancomycin in critically ill patients. Methods: We first performed a systematic evaluation of various models on retrospectively collected pharmacokinetic data in critically ill patients and then selected the best performing model. This model was implemented in the Insight Rx clinical decision support tool and prospectively validated in a multicentre study in critically ill patients. The predictive performance was obtained as mean prediction error and relative root mean squared error. Results: We identified 5 suitable population pharmacokinetic models. The most suitable model was carried forward to a prospective validation. We found in a prospective multicentre study that the selected model could accurately and precisely predict the vancomycin pharmacokinetics based on a previous measurement, with a mean prediction error and relative root mean squared error of respectively 8.84% (95% confidence interval 5.72–11.96%) and 19.8% (95% confidence interval 17.47–22.13%). Conclusion: Using a systematic approach, with a retrospective evaluation and prospective verification we showed the suitability of a model to predict vancomycin pharmacokinetics for purposes of model-informed precision dosing in clinical practice. The presented methodology may serve a generic approach for evaluation of pharmacometric models for the use of model-informed precision dosing in the clinic.

Originele taal-2Engels
Pagina's (van-tot)2497-2506
Aantal pagina's10
TijdschriftBritish Journal of Clinical Pharmacology
Nummer van het tijdschrift12
StatusGepubliceerd - dec. 2020
Extern gepubliceerdJa


Duik in de onderzoeksthema's van 'Prospective validation of a model-informed precision dosing tool for vancomycin in intensive care patients'. Samen vormen ze een unieke vingerafdruk.

Citeer dit